Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2011-03-15
2011-03-15
Marvich, Maria B (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C435S456000, C435S325000, C424S199100, C424S233100
Reexamination Certificate
active
07906111
ABSTRACT:
Sequences of novel adeno-associated virus capsids and vectors and host cells containing these sequences are provided. Also described are methods of using such host cells and vectors in production of rAAV particles. AAV-mediated delivery of therapeutic and immunogenic genes using the vectors of the invention is also provided.
REFERENCES:
patent: 5866552 (1999-02-01), Wilson et al.
patent: 6498244 (2002-12-01), Patel et al.
patent: 6759237 (2004-07-01), Wilson et al.
patent: 7056502 (2006-06-01), Hildinger et al.
patent: 7198951 (2007-04-01), Gao et al.
patent: 7588772 (2009-09-01), Kay et al.
patent: 2003/0138772 (2003-07-01), Gao et al.
patent: 2003/0228282 (2003-12-01), Gao et al.
patent: 2004/0057931 (2004-03-01), Wilson et al.
patent: 2004/0057932 (2004-03-01), Wilson et al.
patent: 2004/0057933 (2004-03-01), Wilson et al.
patent: 2005/0014262 (2005-01-01), Gao et al.
patent: 2007/0243526 (2007-10-01), Kay et al.
patent: 1310571 (2006-02-01), None
patent: WO 98/09657 (1998-03-01), None
patent: WO 00/28061 (2000-05-01), None
patent: WO 01/83692 (2001-11-01), None
patent: WO 03/042397 (2003-05-01), None
patent: WO 03/052051 (2003-06-01), None
patent: WO 03/052052 (2003-06-01), None
patent: WO03052052 (2003-06-01), None
Guo et al, Protein tolerance to random amino acid change, PNAS, 2004, vol. 101 (25), pp. 9205-9210.
Lesk et al, Prediction of Protein Function from Protein Sequence and Structure, p. 27 and 28, downloaded Sep. 16, 2007.
Richard, Protein stability: still an unsolved problem (1997) Cell Mol. Life Sci. 53:790-80.
Gao et al, Adeno-Associated Viruses Undergo Substantial Evolution in Primates During Natural Infections, PNAS, vol. 100, No. 10, pp. 6081-6086, (May 13, 2003).
Gao et al, Novel Adeno-Associated Viruses From Rhesus Monkeys as Vectors for Human Gene Therapy, PNAS, vol. 99, No. 18, pp. 11854-11859, (Sep. 3, 2002).
Grimm et al, From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-Associated Virus (AAV) as Novel Vectors for Human Gene Therapy, Current Gene Therapy, vol. 3, No. 4, pp. 281-304, (Aug. 2003).
Rutledge et al, Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2, Journal of Virology, vol. 72, pp. 309-319, (Jan. 1998).
Rabinowitz et al, Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity, vol. 76, No. 2, pp. 791-801, (Jan. 2002).
Gao et al, Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues, Journal of Virology, vol. 78, No. 12, pp. 6381-6388, (Jun. 2004).
Gao et al, Erythropoietin Gene Therapy Leads to Autoimmune Anemia in Macaques, Blood, vol. 103, No. 9, (May 1, 2004).
Alvira Mauricio R.
Gao Guangping
Vandenberghe Luc H.
Wilson James M.
Howson & Howson LLP
Marvich Maria B
The Trustees of the University of Pennsylvania
LandOfFree
Adeno-associated virus (AAV) clades, sequences, vectors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adeno-associated virus (AAV) clades, sequences, vectors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adeno-associated virus (AAV) clades, sequences, vectors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2704657